Pharma News, 2017

A new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease.

LONDON (Reuters) - Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a state-backed private equity fund.

New Teva CEO Kåre Schultz is getting down to business—and quickly.

It turns out that the quarter-crushing $575 million that drug wholesaler AmerisourceBergen set aside to settle civil litigation with the Justice Department was not enough.

Last year, real-world data showed that SGLT2 diabetes drugs could significantly cut heart failure hospitalizations and all-cause deaths.

Isodiol International Inc.

Singapore’s pharmaceutical market is expected to increase from $903m in 2016 to $1.

Shares in San Franciscan biotech Nektar Therapeutics (Nasdaq.

LONDON (Reuters) - An experimental therapy for people with schizophrenia that brings them face to face with a computer avatar representing the tormenting voices in their heads has proved promi...

Innate Pharma SA (the "Company" - Euronext Paris.

Cytokinetics (NASDAQ.

The Food and Drug Administration has approved Cipla’s generic of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension).